In this episode, Joe interviews Deborah C. Mash, Ph.D.: neuroscientist; Professor Emerita of Neurology and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine; and leading researcher in addiction and brain disorders for over 30 years. She is also the CEO and Founder of DemeRx Inc., a clinical stage drug development […]
The post PT448 – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy appeared first on Psychedelics Today.
